Agentix Corp. (AGTX) stock
AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$0.02+0.00 (0.00%)
Close on Oct 16, 2026Market cap $801.34KP/E –Yield –
Agentix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Agentix's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.53K. For fiscal 2026 it was -$108.53K. The highest annual figure on record is -$12.58K in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$108.53K | – |
| FY2025 | Mar 31, 2025 | -$125.08K | – |
| FY2024 | Mar 31, 2024 | -$110.43K | – |
| FY2021 | Aug 31, 2021 | -$420.98K | – |
| FY2019 | Aug 31, 2019 | -$62.03K | – |
| FY2018 | Aug 31, 2018 | -$51.56K | – |
| FY2017 | Aug 31, 2017 | -$76.42K | – |
| FY2016 | Aug 31, 2016 | -$12.58K | – |
| FY2015 | Aug 31, 2015 | -$186.92K | – |
| FY2014 | Aug 31, 2014 | -$193.90K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$26.37K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $14.78K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$7.94K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $3.00K | -59.3% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$118.37K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$43.06K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$87.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $7.38K | -86.8% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$2.40K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$66.20K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$37.17K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $55.70K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$62.76K | – |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -$6.04K | -151100.0% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | -$93.04K | – |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | -$90.25K | – |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | -$231.66K | -798934.5% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $4 | – |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -$48 | – |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -$32 | – |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $29 | – |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -$10.94K | – |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | -$11.97K | -16964.8% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | -$39.15K | – |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -$23.44K | – |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -$1.04K | – |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $71 | – |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -$27.16K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -$11.57K | – |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -$30.47K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -$13.88K | -2509.0% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -$20.50K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -$675 | – |
| Q3 FY2016CQ2 2016 | May 31, 2016 | -$5.65K | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $576 | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | -$6.82K | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | -$19.65K | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | -$35.28K | – |
| Q2 FY2015CQ1 2015 | Feb 28, 2015 | -$68.59K | – |
See a number that looks wrong?